Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.
Julie KovářováAndrew W PountainDavid WildridgeStefan K WeidtFrédéric BringaudRichard J S BurchmoreFiona AchcarMichael P BarrettPublished in: PLoS pathogens (2018)
Transketolase (TKT) is part of the non-oxidative branch of the pentose phosphate pathway (PPP). Here we describe the impact of removing this enzyme from the pathogenic protozoan Leishmania mexicana. Whereas the deletion had no obvious effect on cultured promastigote forms of the parasite, the Δtkt cells were not virulent in mice. Δtkt promastigotes were more susceptible to oxidative stress and various leishmanicidal drugs than wild-type, and metabolomics analysis revealed profound changes to metabolism in these cells. In addition to changes consistent with those directly related to the role of TKT in the PPP, central carbon metabolism was substantially decreased, the cells consumed significantly less glucose, flux through glycolysis diminished, and production of the main end products of metabolism was decreased. Only minor changes in RNA abundance from genes encoding enzymes in central carbon metabolism, however, were detected although fructose-1,6-bisphosphate aldolase activity was decreased two-fold in the knock-out cell line. We also showed that the dual localisation of TKT between cytosol and glycosomes is determined by the C-terminus of the enzyme and by engineering different variants of the enzyme we could alter its sub-cellular localisation. However, no effect on the overall flux of glucose was noted irrespective of whether the enzyme was found uniquely in either compartment, or in both.
Keyphrases
- induced apoptosis
- oxidative stress
- cell cycle arrest
- wild type
- endoplasmic reticulum stress
- escherichia coli
- mass spectrometry
- cell death
- dna damage
- cell proliferation
- blood glucose
- type diabetes
- copy number
- cystic fibrosis
- endothelial cells
- pi k akt
- insulin resistance
- wastewater treatment
- biofilm formation
- toxoplasma gondii